Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus

Cochrane Database of Systematic Reviews

Volumn 2009, Issue 1, 2005, Pages

  Vermeire, Etienne IJJ ^a   Wens, Johan ^a   Van Royen, Paul ^a   Biot, Yves ^b   Hearnshaw, Hilary ^c   Lindenmeyer, Antje ^d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b General Practitioner   (Belgium)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH BEHAVIOR; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REVIEW;

DIABETES MELLITUS, TYPE 2; HEALTH BEHAVIOR; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIALS;

EID: 21844434480     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003638.pub2     Document Type: Review

References (124)

1. Bradshaw C, McColl E, Eccles M, Bryce C, Sampson R. Can we improve the education for type 2 diabetes patients in general practice?. Practical Diabetes International 1999;16(8):241-5. [EndNote 96]
2. Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Martinez-Gonzalez MA. Intervention study for smoking cessation in diabetic patients. Diabetes Care 2000;23(10):1455-60. [EndNote 97]
3. Clarke J, Crawford A, Nash DB. Evaluation of a comprehensive diabetes disease management program: progress in the struggle for sustained behavior change. Disease management 2002;5(2):77-86. [EndNote 94]
4. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. The Annals of Pharmacotherapy 1998;32:636-41. [EndNote 34]
5. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. American Journal of Medical Quality 2000;15(4):137-42. [EndNote 60]
6. Diehl AK, Sugarek NJ, Bauer RL. Medication compliance in non-insulin-dependent diabetes: a randomized comparison of chlorpropamide and insulin. Diabetes Care 1985;8(3):219-23. [EndNote 19]
7. Hopper SV, Miller JP, Birge C, Swift J. A randomized study of the impact of home health aides on diabetic control and utilization patterns. American Journal Public Health 1984;74(6):600-2. [EndNote 64]
8. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. The Annals of Pharmacotherapy 1996;30:238-43. [EndNote 36]
9. Jiang Y-D, Chuang L-M, Wu H-P, Shiau Q-J, Wang C-H, Lee Y-J, Juang J-H, et al. Assessment of the function and effect of diabetes education programs in Taiwan. Diabetes Research and Clinical Practice 1999;46:177-82. [EndNote 72]
10. Krier BP, Parker RD, Grayson D, Byrd G. Effect of diabetes education on glucose control. The Journal of the Louisiana State Medical Society: official organ of the Louisiana State Medical Society 1999;151:86-92. [EndNote 54]
11. Matsuyama JR, Mason BJ, Jue SG. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. The Annals of Pharmacotherpay 1993;27:851-5. [EndNote 2]
12. Mease A, Whitlock WL, Brown A, Moore K, Pavlascak, Dingbaum A, Lacefield D, Buker K, Xenakis S. Telemedicine improved diabetic management. Military Medicine 2000;165(8):579-84. [EndNote 76]
13. Paes AHP, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20(10):1512-7. [EndNote 3]
14. Piette JD, Weinberger M, Kraemer FP, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a department of veteran affairs health care system. Diabetes Care 2001;24(2):202-8. [EndNote 92]
15. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmocologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clinical pharmacology and therapeutics 1988;44:540-5. [EndNote 41]
16. Rachmani R, Levi Z, Slavachevski I, Avin M, Ravid M. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus - a randomized prospective study. Diabetic Medicine 2002;19:385-92. [EndNote 55]
17. Rosenkranz S. Polaroid-Fundusfotografie erhöht die Patientencompliance beim Screening auf diabetische Retinopathie. Diabetes und Stoffwechsel 1006;5:69-75. [EN 29]
18. Simmons D, Upjohn M, Gamble GD. Can medication packaging improve glycemic contol and blood pressure in type 2 diabetes?. Diabetes Care 2000;23(2):153-6. [EndNote 93]
19. Skaer TL, Sclar DA, Markowski DJ, Won JKH. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabe. 1993; Vol. 18:295-9. [EndNote 42]
20. Smith DM, Norton JA, Weinberger M, McDonald CJ, Katz BP. Increasing prescribed office visits. A controlled trial in patients with diabetes mellitus. Medical Care 1986;24(3):189-99. [EndNote 62]
21. White N, Carnahan J, Nugent CA, Iwaoka T, Dodson MA. Management of obese patients with diabetes mellitus: comparison of advice education with group management. Diabetes Care 1986;9(5):490-6. [EndNote 91]
22. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Diabetes care 1990;11(10):1044-50. [EndNote 53]
23. Arauz AG, Sanchez G, Padilla G, Fernandez M, Rosello M, Guzman S. A communtiy diabetes educational intervention at the primary-care level [Intervencion educativa comunitaria sobre la diabetes en el ambito de la atencion primaira]. Pan Am J Public Health 2001;9(3):145-3. [EndNote 31]
24. Barcelo A, Robles S, White F, Jadue L, Vega J. An intervention to improve diabetes control in Chile [Una intervencion para mejorar el control de la diabetes en Cile]. Pan American journal of public health 2001;10(5):328-33. [EndNote 33]
25. Basa RP, McLeod B. Evaluation of a diabetes specialty centre: structure, process and outcome. Patient Education Counseling 1995;25:23-9. [EndNote 79]
26. Benjamin EM, Schneider MS, Hinchey KT. Implementing practice guidelines for diabetes care using problem-based learning. Diabetes Care 1999;22(10):1672-8. [EndNote 43]
27. Brown SA, Hanis CL. Culturally competent diabetes education for Mexican Americans: the Starr County Study. Diabetes Educator 1999;25(2):226-36. [EndNote 45]
28. Cabrera-Pivaral CE, Gonzalez-Perez G, Vega-Lopez G, Gonzalez-Hita M, Centeno-Lopez M, Gonzalez-Ortiz M, et al. Effects of behavior-modifying education in the metabolic profile of the Type 2 diabetes mellitus patient. Journal of Diabetes and its Complications 2000;14:322-6. [EndNote 46]
29. Campbell AM, Redman S, Moffitt PS, Sanson-Fisher RW. The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: a randomized trial. The Diabetes Educatore 1996;22(4):379-86. [EndNote 49]
30. Coleman R, Gill G, Wilkinson D. Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa. Bulletin of the World Health Organization 1998;76(6):633-40. [EN 35]
31. Cooper HC, Lorains JW. Managing poor control in type 2 diabetes. Practical Diabetes International 1998;15(6):173-7. [EndNote 37]
32. d'Eramo-Melkus GA, Wylie-Rosett J, Hagan JA. Metabolic impact of education in NIDDM. Diabetes Care 1992;15(7):864-9. [EndNote 52]
33. Day JL, Metcalfe J, Johnson P. Benefits provided by an integrated education and clinical diabetes centre: a follow-up study. Diabetic Medicine 1992;9:855-9. [EndNote 71]
34. de Grauw WJC, van de Lisdonk EH, van Gerwen WHEM, van den Hoogen HJM, van Weel C. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?. B J Gen Pract 2001;51:527-32. [EN 7]
35. de Sonnaville JJJ, Bouma M, Colly LP, Devillé W, Wijkel D, Heine RJ. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practi: 2-year follow-up study. Diabetologia 1997;40:1334-40. [EndNote 78]
36. Domenech MI, Assad D, Mazzei ME, Kronsbein P, Gagliardino JJ. Evaluation of the effectiveness of an ambulatory teaching/trteatment programme for non-insulin dependent (type 2) diabetic patients. Acta diabetologica 1995;32:143-7. [EndNote 8]
37. Estey AL, Tan MH, Mann K. Follow-up intervention: its effect on compliance behavior to a diabetes regimen. Diabetes Educator 1990;16(4):291-5. [EndNote 9]
38. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P, Besse A, et al. Is glucose self-monitoring beneficial in on-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabète & Métabolisme 1989;15:255-60. [EndNote 98]
39. Fritsche A, Stumvoll M, Goebbel S, Reinauer KM, Schmülling RM, Häring HU. Long term effect of a structurend inpatient diabetes teaching and treatment programme in type 2 diabetic patients: influence of mode of follow-up. Patient Education Counseling 1999;46:135-41. [EndNote 67]
40. Greenfield S, Kaplan SH, Sillman RA, Sullivan L, Manning W, D'Agostino R, et al. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. Diabetes Care 1994;17(Suppl 1):32-9. [EndNote 17]
41. Guillausseau PJ, Greb W. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily. Diabetes Medidine 2001;27:133-7. [EndNote 13]
42. Halpert RJ, Leung K-M, Nichol JM, Legorreta AP. Effect of multiple patient reminders in improving diabetic retinopahty screening. Diabetes Care 1999;22(5):752-5. [EndNote 84]
43. Hiss RG, Gillard ML, Armbruster BA, McClure LA. Comprehensive evaluation of community-based diabetic patients. Effect of feedback to patients and their physicians: a randomized controlled trial. Diabetes Care 2001;24(4):690-4. [EndNote 57]
44. Hoskins PL, Alford JB, Handelsman DJ, Yue DK, Turtle JR. Comparison of different models of diabetes care on compliance with self-monitoring of blood glucose by memory glucometer. Diabetes Care 1988;11(9):719-24.
45. Jirkovska A, Havlova V, Hrachoviniva T, Fejfarova V, Hosova J, Maskova J, et al. The treatment effectg of education on the metabolic status of type 2 diabetic patients [Lecebny ucinek ambulantniho edukacniho kurzu na metabolicky syndrom u diabetiku 2 typu]. Praktický lékar 2000;80(2):95-8. [EndNote 38]
46. Jones PM. Use of a course on self-control behavior techniques to increase adherence to prescribed frequency for self-monitoring blood glucose. Diabetes Educator 1989;16(4):296-303. [EndNote 95]
47. Karter AJ, Ackerson LM, Darbanian JA, D'Agostino RB, Ferrara A, Liu J. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser permanent diabets regystry. The American journal of medicine 2001;111:1-9. [EndNote 15]
48. Kim WS, Sakano Y. Cognitive-behavioral intervention to chronic disease patients. Jpn J Psychosom Med 1996;36:27-32. [EndNote 23]
49. Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ, the Diabetes Care from Diagnosis Research Team. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. BMJ 1998;317:1202-8. [EndNote 82]
50. Kirkman MS, Weinberger M, Landsman PB, Samsa GP, Shortliffe EA, Simel DL. A telephone-delivered interevention for patients with NIDDM. Diabetes Care 1994;17(8):840-6. [EndNote 1]
51. Kronsbein P, Mühlhauser I, Venhaus A, Jörgens V, Scholz V, Berger M. Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet 1988:1407-10. [EndNote 68]
52. Lo R, Lo B, Wells E, Chard M, Hathaway J. The develoment an d evaluation of a computer-aided diabetes education progam. Australian Journal of Advanced Nursing 1996;13(4):19-27. [EndNote 63]
53. Mazzuca SA, Moorman NH, Wheeler ML, Norton JA, Fineberg NS, Vinicor F, et al. The Diabetes Education Study: a controlled trial of teh effects of diabetes patient education. Diabetes Care 1986;9(1):1-10. [EndNote 18]
54. McDermott RA, Schmidt BA, Sinha A, Mills P. Improving diabetes care in the primary healthcare setting: a randomised cluster trial in romote indigenous communities. MJA 2001;174:497-502. [EndNote 59]
55. Morgan BS, Littell DH. A closer look at teaching and contingency contracting with type II diabetes. Patient Education Counseling 1988;12:145-58. [EndNote 39]
56. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta diabetologica 1994;31:215-9. [EndNote 58]
57. Mulrow C, Bailey S, Sönksen PH, Slavin B. Evaluation of an audiovisual diabetes education program: negative results of a randomized trial of patients with non-insulin-dependent diabetes mellitus. Journal of general internal medicine 1987;2:215-219. [EndNote 74]
58. Neumann L, Weitzman S, Gross J. Improved knowledge of diabetic patients through education of primary care staff. Health Policy 1989;13:103-8. [EndNote 16]
59. Oi K, Komori H. Escape phenomenon with pravastatin during long-term treatment of patients with hyperlipidemia associaqted with diabetes mellitus. Current Therapeutic Research 1998;59(2):130-8. [EndNote 87]
60. Ovhed I, Johansson E, Odeberg H, Rastam L. A comparison of two different team models for treatment of diabetees mellitus in primary care. Scandinavian journal of caring sciences 2000;14:253-8. [EndNote 88]
61. Pieber TR, Holler A, Brunner GA, Schattenberg S, Schnedl WJ, Semlitsch B, et al. Diabetes treatment in Austira 5 years after the St. Vincent Declaration [Diabetesbetreuung in Osterreich 5 Jahre nach der St. Vincent-Erklarung]. Wien Klin Wochenschr 1995;107(15):451-6. [EndNote 89]
62. Pill R, Stott NCH, Rollnick SR, Rees M. A randomized controlled trial of an intervention designed to improve the care given in general practice to type II diabetic patients: patient outcomes and professional ability to change behaviour. Family Practice 1998;15(3):229-35. [EndNote 83]
63. Ridgeway NA, Harvill DR, Harvill LM, Falin TM, Forester GM, Gose OP. Improved control of type 2 diabetes mellitus: a practical education/behavior modification program in a primary care clinic. Southern Medical Journal 1999;92(7):667-72. [EndNote 47]
64. Rubin RR, Peyrot M, Saudek CD. Differential effect of diabetes education on self-regulation and life-style behaviors. Diabetes Care 1991;14(4):335-8. [EndNote 75]
65. Rutten G, Van Eijck J, De Nobel E, Beek M, Van der Velden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Family Practice 1990;7(4):273-8. [EndNote 4]
66. Smith DM, Weinberger M, Katz BP. A controlled trial to increase office visits and reduce hospitalizations of diabetic patients. Journal of General Internal Medicine 1987;2:231-7. [EN 90]
67. Tamai H, Kubota S, Nozaki T. A psychosomatic approach to the treatment of diabtic patients who have difficulty in adhering to a self-care regimen. Shinshin-Igaku 1995;35:33-9. [EndNote 28]
68. Trento M, Passera P, Tomalino M, Bajardi M, Pomero F, Allione A, Vaccari P, Molinatti GM, Porta M. Group visits improve metabolic control in type 2 diabetes. Diabetes Care 2001;24(6):995-1000. [EndNote 86]
69. Tu K-S, McDaniel G, Templeton J. Diabetes self-care knowledge, behaviors, and metabolic control of older adults - The effect of a posteducational follow-up program. Diabetes Educator 1993;19(1):25-30. [EndNote 51]
70. van den Arend IJM, Stolk RP, Rutten GEHM, Schrijvers GJP. Education integrated into structured general practice care for type 2 diabetic patients results in sustained improvement of disease knowledge and self-care. Diabetic Medicine 2000;17:190-7. [EndNote 27]
71. Wedman B, Kahan RS. Diabetes praphic aids used in counseling improve patient compliance. The American dietetic association 1987;87(12):1672-4. [EN 70]
72. Weinberger M, Kirkman MS, Samsa GP, Shortliffe EA, Landsman PB, Cowper PA, et al. A nurse-coordinated intervention for priamry care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. Journal of general internal medicine 1995;10(2):59-66. [EndNote 26]
73. Whitlock WL, Brown A, Moore K, Pavliscsak H, Lanufeld D, Buker K, et al. Telemedicine improved diabetic management. Military medicine 2000;165(8):579-84. [EndNote 76]
74. Wilson W, Pratt C. The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with noninsulin dependent diabetes mellitys (NIDDM). American Journal of Public Health 1987;77:634-5. [EndNote 12]
75. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999;22(Suppl 1):S5-19.
76. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Medicine 1997;14(Suppl.5):S1-85.
77. Borhouts JAJ, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: a systematic review. Pain 198, (77):1-13.
78. Boulé N, Haddad E, Sigal R, Kenny G. Exercise for type 2 diabetes mellitus (Protocol for a Cochrane review). The Cochrane Library 2001, Issue 2.
79. Bouter L, van Dongen MCJM. Epidemiological research. Study design and interpretation. [Epidemiologisch onderzoek. Opzet en interpretatie]. Houten/Antwerpen: Bohn Stafleu Van Loghum, 1991:103-9.
80. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making?. Social Science and Medicine 1992;34:507-13.
81. Donovan JL. Patient decision making. The missing ingredient in compliance research. International Journal of Technology Assessment in Health Care 1995;11:443-5.
82. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, (315):629-34.
83. Fleiss JL. Statistical methods for rates and properties. 2nd Edition. New-York: Wiley, 1981:217-37.
84. Foster DW. Diabetes Mellitus. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin BM, Fauci AS, Kasper DL editor(s). Harrison's Principles of Internal Medicine. 13th Edition. McGraw-Hill, 1994:1979-99.
85. Friedenreich CM, Brant RF, Riboli E. Influence of methodological factors in a pooled analysis of 13 case-control studies of colorectal cancer and dietary fibre. Epidemiology 1994;5:66-79.
86. Goyder E, Irwig L. Screening for diabetes: what are we really doing?. BMJ 1998, (317):1644-6.
87. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the U.S. Preventive Services Task Force. A review of the process. American Journal of Preventive Medicine 2001, (20):21-35.
88. Haynes RB, McKibbon KA, Kanani R, Brouwers MC, Oliver T. Interventions to assist patients to follow prescriptions for medications. The Cochrane Database of Systematic Reviews 1997.
89. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
90. International Diabetes Federation Europe. A desktop guide to type 2 diabetes. 1999.
91. Ismail K, McGuire H, Winkley K. Psychological interventions for improving glycaemic control in patients with diabetes mellitus (Protocol for a Cochran Review). The Cochrane Database of Systematic Reviews 2001, Issue 2.
92. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004;363(9421):1589-1597.
93. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavagham DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996, (17):1-12.
94. Jüni P, Altman DG, Egger M. Assessing the quality of randomised controlled trials. In: Egger M, Smith GD, Altman DG editor(s). Systematic reviews in health care. Meta-analysis in context. London: BMJ Books, 2001.
95. Kinmonth AL, Griffin S, Wareham NJ. Implications of the United Kingdom Prospective Diabetes Study for general practice care of type 2 diabetes. British Journal of General Practice 1999:692-4.
96. Laupacis A, Wells G, Richardson WS, Tugwell P. Users' guide to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 1994;272:234-7.
97. LeBlanc ES, Janowsky J, Nelson HD. Hormone replacement therapy and cognition. Systematic review and meta-analysis. JAMA 2001;285(11):1489-99.
98. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. User's guide to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994;271:1615-9.
99. Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N. Nice Technology Assessment Report. Vol. 7, Health Technology Assessment, 2003.
100. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999, (354):1896-900.
101. Moore H, Summerbell C, Hooper L, Cruicksbank K, Vyas A, Johnstone P, et al. Dietary advice for treatment of type 2 diabetes mellitus in adults. The Cochrane Database of Systematic Reviews 2004, Issue 2.
102. Morris LS, Schulz RM. Patient compliance: an overview. Journal of Clinical Pharmacy and Therapeutics 1992;17:183-95.
103. Nagasawa N, Smith MC, Barnes JH, Fincham JE. Meta-analysis of correlates of diabetes patients' compliance with prescribed medications. Diabetes Educator 1990;16(3):192-200.
104. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-957.
105. Offringa M, Assendelft WJJ, Scholten RJPM. Inleidng in evidence-based medicine. Klinisch handelen gebaseerd op bewijsmateriaal. Houten/Diegem: Bohn Stafleu Van Loghum, 2000. [ISBN 90 313 30663]
106. Renders CM, Valk GD, Griffin S, Wagner EM, van Eijck JThM, et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. The Cochrane Database of Systematic Reviews 2001, Issue 1.
107. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient noncompliance: a meta-analysis. Care 1998;36(8):1138-61.
108. Schroeder K, Fahey T, Ebrahim S. Interventions used to improve the adherence with treatment in patients with high blood pressure in ambulatory settings (Protocol for a Cochrane Review). The Cochrane Database of Systematic Reviews 2002, Issue 1.
109. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Archives of internal medicine 2004;164(7):722-32.
110. Schulze KF, Chalmers I, Hayens RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, (273):408-12.
111. Sterne JC, Egger M, Smith GD. Investigating and dealing with publication and other biases. In: Egger M, Smith GD, Altman DG editor(s). Systematic reviews in health care. Meta-analysis in context. 2nd Edition. London: BMJ Books, 2001:189-208.
112. Stoop DF, Berlin JA, Morton SC, Olkin I, Willianson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000;283:2008-12.
113. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, (352):837-53.
114. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, (352):854-65.
115. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and rsik of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 1998, (317):703-13.
116. Verhagen AP, de Vet HCV, de Bie RA, Boers M, van den Brandt PA. The art of quality assessment of RCTs included in systematic reviews. Journal of Clinical Epidemiology 2001;54:651-4.
117. Vermeire E. Diabetes care: concordance versus compliance [Diabeteszorg: concordance versus compliance]. Minerva (Huisarts Nu) 1999;28(3):120-1.
118. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics 2001;26:331-42.
119. Wallach J. Interpretation of diagnostic tests. 2nd Edition. Philadelphia: Lippincott, Williams and Wilkins, 2000.
120. Wens J, Vermeire E, van Driel M. The United Kingdom Prospective Diabetes Study: study design [The United Kingdom Prospective Diabetes Study: onderzoeksopzet]. Minerva (Huisarts Nu) 1999;28(3):122-4.
121. Wens J, Vermeire E, Van Royen P, Hearnshaw H. A systematic review of adherence with medications for diabetes: response to Cramer. Diabetes Care 2004;27(9):2284.
122. WHO Expert Committee on Diabetes Mellitus. Second report. Technical Report Series 646. Geneva: World Health Organization, 1980.
123. World Health organization. Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series No 727. Geneva: WHO, 1985.
124. Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15:539-53.